These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33976733)

  • 21. Overexpression of SLC35F2 is a potential prognostic biomarker for lung adenocarcinoma.
    Zheng Q; Li M; Qiu Y; Yang J; Cao Y
    Heliyon; 2024 Jan; 10(1):e23828. PubMed ID: 38187235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of EMID1 Accelerates to a Favorable Prognosis and Immune Infiltration in Lung Adenocarcinoma.
    Shao Y; Zheng Z; Li S; Yang G; Qi F; Fei F
    J Oncol; 2022; 2022():5185202. PubMed ID: 36245990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low expression of IL6R predicts poor prognosis for lung adenocarcinoma.
    Sun G; Wang T; Shi M; Zhou H; Wang J; Huang Z; Zhang H; Shi J
    Ann Transl Med; 2021 Jul; 9(13):1057. PubMed ID: 34422969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression.
    Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X
    Front Oncol; 2022; 12():927988. PubMed ID: 35756681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of NDUFAF2 in Lung Adenocarcinoma Is a Novel Independent Prognostic Biomarker.
    Zou K; Gao P; Xu X; Zhang W; Zeng Z
    Comput Math Methods Med; 2023; 2023():2912968. PubMed ID: 36703939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of LIMCH1 predicts poor prognosis in patients with surgically resected Lung Adenocarcinoma: A study based on Immunohistochemical Analysis and Bioinformatics.
    Cao H; Zhao J; Chen Z; Sun W; Ruan K; Zhou J; Zhou J
    J Cancer; 2021; 12(1):181-189. PubMed ID: 33391414
    [No Abstract]   [Full Text] [Related]  

  • 27. INHA acts as a novel and potential biomarker in lung adenocarcinoma and shapes the immune-suppressive tumor microenvironment.
    Zhang X; Zhang X; Jiang D; Zheng W; Wang H; Tian Y; Cheng B
    Transl Oncol; 2023 Jul; 33():101679. PubMed ID: 37105130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma.
    Guo Z; Huang J; Wang Y; Liu XP; Li W; Yao J; Li S; Hu W
    Front Genet; 2020; 11():547. PubMed ID: 32595698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HMGA1 is a Prognostic Biomarker and Correlated with Glycolysis in Lung Adenocarcinoma.
    Ma Y; Ma X; Du B; Li X; Li Y
    J Cancer; 2024; 15(10):2913-2927. PubMed ID: 38706894
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognostic and immunological roles of heat shock protein A4 in lung adenocarcinoma.
    Wu X; Yang SY; Zhang YH; Fang JZ; Wang S; Xu ZW; Zhang XJ
    World J Clin Oncol; 2024 Jan; 15(1):45-61. PubMed ID: 38292659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of abnormal spindle-like microcephaly-associated (ASPM) increases tumor aggressiveness and predicts poor outcome in patients with lung adenocarcinoma.
    Feng Z; Zhang J; Zheng Y; Liu J; Duan T; Tian T
    Transl Cancer Res; 2021 Feb; 10(2):983-997. PubMed ID: 35116426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NCAPH is a prognostic biomarker and associated with immune infiltrates in lung adenocarcinoma.
    Li C; Meng J; Zhang T
    Sci Rep; 2022 Jun; 12(1):9578. PubMed ID: 35688915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma.
    Wang J; Yin X; Zhang YQ; Ji X
    Front Genet; 2021; 12():639254. PubMed ID: 33708243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-195-3p is a Novel Prognostic Biomarker Associated with Immune Infiltrates of Lung Adenocarcinoma.
    Lao Y; Li T; Xie X; Chen K; Li M; Huang L
    Int J Gen Med; 2022; 15():191-203. PubMed ID: 35023957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor.
    Yu L; Qiao R; Xu J; Han B; Zhong R
    Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CKS2 Overexpression Correlates with Prognosis and Immune Cell Infiltration in Lung Adenocarcinoma: A Comprehensive Study based on Bioinformatics and Experiments.
    Wang Z; Zhang M; Wu Y; Yu Y; Zheng Q; Li J
    J Cancer; 2021; 12(23):6964-6978. PubMed ID: 34729099
    [No Abstract]   [Full Text] [Related]  

  • 37. CASC5 is a potential tumour driving gene in lung adenocarcinoma.
    Cui Y; Zhang C; Ma S; Guo W; Cao W; Guan F
    Cell Biochem Funct; 2020 Aug; 38(6):733-742. PubMed ID: 32283571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced expression of queuine tRNA-ribosyltransferase 1 (
    Ma Q; He J
    Ann Transl Med; 2020 Dec; 8(24):1658. PubMed ID: 33490170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes.
    Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
    Cancer Cell Int; 2021 Apr; 21(1):219. PubMed ID: 33858449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a four-gene panel predicting overall survival for lung adenocarcinoma.
    Li C; Long Q; Zhang D; Li J; Zhang X
    BMC Cancer; 2020 Dec; 20(1):1198. PubMed ID: 33287749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.